Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Merrimack Pharmaceuticals, Inc
About MACK
Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company. The Company does not have any ongoing research or development activities and is seeking potential acquirers for its remaining preclinical and clinical assets. It is entitled to receive payments related to its sale of ONIVYDE to Ipsen S.A. and also its contingent payments related to its sale of MM-121 and MM-111 to Elevation Oncology, Inc. These payments are payable by Ipsen upon approval by the United States Food and Drug Administration (FDA) of Onivyde for certain additional clinical indications. ONIVYDE is approved by FDA to market as a first-line treatment of metastatic adenocarcinoma on the pancreas. It is also entitled to receive payments related to its sale of anti-HER3 programs to Elevation Oncology, Inc. The Company’s wholly owned subsidiaries include Merrimack Pharmaceuticals UK Limited and Merrimack Securities Corporation.
Find out what a historical investment in Merrimack Pharmaceuticals, Inc would be worth today using our MACK stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy MACK shares in Australia?
Buying MACK shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Merrimack Pharmaceuticals, Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in MACK
What is the ticker symbol of Merrimack Pharmaceuticals, Inc?
The ticker symbol for Merrimack Pharmaceuticals, Inc is MACK.
How much is one share of MACK?
One share of MACK is valued at $15.15 as of 16 May 2026.
What is the market capitalisation of Merrimack Pharmaceuticals, Inc MACK?
As of 16 May 2026 Merrimack Pharmaceuticals, Inc has a market cap of -.
What is the 52-week high for Merrimack Pharmaceuticals, Inc stock?
The Merrimack Pharmaceuticals, Inc 52-week high stock price is $NaN.
What is the 52-week low for Merrimack Pharmaceuticals, Inc stock?
The Merrimack Pharmaceuticals, Inc 52-week low stock price is $NaN.
Can I buy MACK shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy MACK shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MACK on Stake
- Buy MACK from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of MACK from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
MACK related stocks